ロード中...

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Obese Population

BACKGROUND: Dalbavancin is a lipoglycopeptide with activity against Gram-positive pathogens responsible for ABSSSI, including methicillin-resistant Staphylococcus aureus (MRSA), and is FDA-approved as a single- or two-dose regimen. The objective of this study was to assess efficacy and safety of dal...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Georgiades, Benjamin, Rappo, Urania, Gonzalez, Pedro L, McGregor, Jennifer S, Chen, Jie, McCarthy, Matthew
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631734/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.114
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!